NDC 58198-9725 - Atopica for Cats
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 58198-9725
- Package NDCs from labels
- 58198-9725-1, 58198-9725-2
- Manufacturer
- Elanco US Inc.
- Effective date
- 2026-07-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Atopica™ for Cats (cyclosporine oral solution) USP MODIFIED 100 mg/mL | Elanco US Inc. | 2026-07-22 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 58198-9725-1 | Atopica for Cats | 5 mL in 1 BOTTLE, GLASS | SOLUTION | 5 | 11 | |
| 58198-9725-1 | Atopica for Cats | 1 in 1 CARTON | SOLUTION | 1 | 11 | |
| 58198-9725-2 | Atopica for Cats | 1 in 1 CARTON | SOLUTION | 1 | 11 | |
| 58198-9725-2 | Atopica for Cats | 17 mL in 1 BOTTLE, GLASS | SOLUTION | 17 | 11 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 58198-9725 | ATOPICA FOR CATS (CYCLOSPORINE) SOLUTION [ELANCO US INC.] | 10 | 4 package rows | 20211214_47f70173-a1d9-4156-9a7f-0f296e5dd64b.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| CYCLOSPORINE | ACTIVE INGREDIENT | 83HN0GTJ6D | ATOPICA FOR CATS (CYCLOSPORINE) SOLUTION [NOVARTIS ANIMAL HEALTH US, INC.] | 6 | |
| CYCLOSPORINE | ACTIVE MOIETY | 83HN0GTJ6D | ATOPICA FOR CATS (CYCLOSPORINE) SOLUTION [NOVARTIS ANIMAL HEALTH US, INC.] | 6 | |
| .ALPHA.-TOCOPHEROL | INACTIVE INGREDIENT | H4N855PNZ1 | ATOPICA FOR CATS (CYCLOSPORINE) SOLUTION [NOVARTIS ANIMAL HEALTH US, INC.] | 6 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | ATOPICA FOR CATS (CYCLOSPORINE) SOLUTION [NOVARTIS ANIMAL HEALTH US, INC.] | 6 | |
| CASTOR OIL | INACTIVE INGREDIENT | D5340Y2I9G | ATOPICA FOR CATS (CYCLOSPORINE) SOLUTION [NOVARTIS ANIMAL HEALTH US, INC.] | 6 | |
| CORN OIL | INACTIVE INGREDIENT | 8470G57WFM | ATOPICA FOR CATS (CYCLOSPORINE) SOLUTION [NOVARTIS ANIMAL HEALTH US, INC.] | 6 | |
| NITROGEN | INACTIVE INGREDIENT | N762921K75 | ATOPICA FOR CATS (CYCLOSPORINE) SOLUTION [NOVARTIS ANIMAL HEALTH US, INC.] | 6 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | ATOPICA FOR CATS (CYCLOSPORINE) SOLUTION [NOVARTIS ANIMAL HEALTH US, INC.] | 6 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CYCLOSPORINE | CYCLOSPORINE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 1952d4c7-a40e-4924-b669-c41400774cb9 | 2026-11-05 | Boxed warning, Warnings, Adverse reactions | 83HN0GTJ6D |
| Verkazia | CYCLOSPORINE | Santen Incorporated | c795cd2f-89da-78e3-e053-2a95a90a9422 | 2026-11-04 | Warnings, Adverse reactions | 83HN0GTJ6D |
| Cyclosporine | CYCLOSPORINE | Aurobindo Pharma Limited | aaf79e72-26bf-4152-9cd1-10d8c30fa4fe | 2026-09-18 | Boxed warning, Warnings, Adverse reactions | 83HN0GTJ6D |
| CycloSPORINE, Modfied | CYCLOSPORINE | Apotex Corp. | 5baaf78c-90f6-abcf-52c8-814490f3cf9f | 2026-09-10 | Boxed warning, Warnings, Adverse reactions | 83HN0GTJ6D |
| Cyclosporine | CYCLOSPORINE | Strides Pharma Science Limited | c36132b2-3ec7-4c43-a25e-75cbdbe3d88d | 2026-08-27 | Boxed warning, Warnings, Adverse reactions | 83HN0GTJ6D |
| Cyclosporine | CYCLOSPORINE | Cipla USA Inc. | df356f62-0d63-459a-842e-208c48c6370a | 2026-08-21 | Warnings, Adverse reactions | 83HN0GTJ6D |
| Neoral | CYCLOSPORINE | Novartis Pharmaceuticals Corporation | 94461af3-11f1-4670-95d4-2965b9538ae3 | 2026-08-10 | Boxed warning, Warnings, Adverse reactions | 835886 83HN0GTJ6D |
| Sandimmune | CYCLOSPORINE | Novartis Pharmaceuticals Corporation | 5e5926a7-1de0-4b54-a5c0-286b6200ff82 | 2026-07-10 | Boxed warning, Warnings, Adverse reactions | 83HN0GTJ6D |
| CEQUA | CYCLOSPORINE | Sun Pharmaceutical Industries, Inc. | 48c3d8a3-4289-4b52-9189-58b48596095c | 2026-06-15 | Warnings, Adverse reactions | 83HN0GTJ6D |
| Verkazia | CYCLOSPORINE | Harrow Eye, LLC | 48651d30-9e6e-74b0-e063-6294a90a8337 | 2026-06-03 | Warnings, Adverse reactions | 83HN0GTJ6D |
| CYCLOSPORINE | CYCLOSPORINE | Upsher-Smith Laboratories, LLC | f7e4a2f0-ea2a-449b-bc6d-a6ea3d47b850 | 2026-05-22 | Warnings, Adverse reactions | 83HN0GTJ6D |
| Cyclosporine | CYCLOSPORINE | Apotex Corp. | bfca7088-fe93-abb9-3ec3-e6f5710a69c6 | 2026-04-22 | Boxed warning, Warnings, Adverse reactions | 83HN0GTJ6D |
| VEVYE | CYCLOSPORINE OPHTHALMIC SOLUTION | Harrow Eye, LLC | 0a60fccf-7e1b-44fe-e063-6394a90aadd5 | 2026-02-26 | Warnings, Adverse reactions | 83HN0GTJ6D |
| CYCLOSPORINE | CYCLOSPORINE | Saptalis Pharmaceuticals, LLC | ff4dc2fc-667a-489a-b798-8d11cddfe716 | 2025-12-09 | Warnings, Adverse reactions | 83HN0GTJ6D |
| Cyclosporine | CYCLOSPORINE | Qilu Pharmaceutical Co., Ltd. | 341c3442-ee7c-4c9f-807d-1ac988b9a60a | 2025-11-07 | Boxed warning, Warnings, Adverse reactions | 83HN0GTJ6D |
| Restasis MultiDose | CYCLOSPORINE | Allergan, Inc. | 7224d810-bb96-4682-a942-3355e6e8061a | 2025-08-21 | Warnings, Adverse reactions | 83HN0GTJ6D |
| Cyclosporine | CYCLOSPORINE | Devatis Inc. | 7bb2078d-17c2-4e6a-9f61-26c7ecbce945 | 2025-02-17 | Warnings, Adverse reactions | 83HN0GTJ6D |
| Cyclosporine | CYCLOSPORINE | Apotex Corp | 70c8a4a6-ebe2-457f-a626-400c338cec2d | 2024-09-23 | Warnings, Adverse reactions | 83HN0GTJ6D |
| Cyclosporine | CYCLOSPORINE | KVK-TECH, INC. | a7040dc6-063b-40ee-8f2a-153e87b08430 | 2024-09-23 | Warnings, Adverse reactions | 83HN0GTJ6D |
| RESTASIS | CYCLOSPORINE | Allergan, Inc. | 8e24af2b-bc1c-4849-94f2-6df950cdca89 | 2024-09-09 | Warnings, Adverse reactions | 83HN0GTJ6D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.